The evaluation of manufacturing issues in the product development process

Many companies still do not achieve the success rates they desire with new product introductions to the market. A method has been developed to aid companies to self-evaluate their product development processes (PDP). The method meets an identified need for a non-prescriptive procedure to evaluate an existing or proposed PDP at a detailed level, both in the context of the company's own products, processes, procedures and markets, and in the context of accepted good practice. The specification and development of the process and facilities needed for the manufacture of a product are identified as fundamental generic issues within the PDP that must be handled effectively to achieve successful product outcomes. The paper describes the main constructs of the evaluation method in relation to manufacturing issues, and presents results and findings from trials conducted in industry. It is seen that great care is needed to ensure that company practitioners make objective assessments of the important factors. Further work is planned to develop the method as an interactive computer tool and to conduct more trials

Applications of Solid Freeform Fabrication at the Naval Research Laboratory

Solid Freeform Fabrication (SFF) and related techniques are used at the Naval Research Laboratory (NRL) for a variety of materials related investigations. Research and applications conducted over the past few years are described including: Helisys Laminated Object Manufacturing System (LOMS) fabrication of: ceramic piezoelectric actuators, tooling for multifunctional materials, and anatomical prototypes for surgical visualization; fabrication of mesoscale electronic and sensor components using a laser forward transfer direct write technique; and visualization of complex, 3-D microstructures using a Stratasys Fused-Deposition Modeler. The paper closes with a brief overview of future SFF related work at the NRL.Support for this work from DARPA, Office of Naval Research, and the Naval Research Laboratory Core Research Program is gratefully acknowledged.Mechanical Engineerin

Magneto-Transport Properties of Doped RuSr2_2GdCu2_2O8_8

RuSr$_2$GdCu$_2$O$_8$, in which magnetic order and superconductivity coexist with $T_{Magnetic}$$\gg$$T_c$, is a complex material which poses new and important questions to our understanding of the interplay between magnetic and superconducting (SC) order. Resistivity, Hall effect and thermopower measurements on sintered ceramic RuSr$_2$GdCu$_2$O$_8$ are presented, together with results on a broad range of substituted analogues. The Hall effect and thermopower both show anomalous decreases below $T_{Magnetic}$ which may be explained within a simple two-band model by a transition from localized to more itinerant behavior in the RuO$_2$ layer at $T_{Magnetic}$.Comment: 10 pages, 7 figures, submitted to Phys. Rev. B., correspondence to [email protected]

Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitment.

OBJECTIVES: To characterize the host response to dendritic cell-based immunotherapy and subsequent combined antiretroviral therapy (cART) interruption in HIV-1-infected individuals at the plasma protein level. DESIGN: An autologous dendritic cell (DC) therapeutic vaccine was administered to HIV-infected individuals, stable on cART. The effect of vaccination was evaluated at the plasma protein level during the period preceding cART interruption, during analytical therapy interruption and at viral reactivation. Healthy controls and post-exposure prophylactically treated healthy individuals were included as controls. METHODS: Plasma marker ('analyte') levels including cytokines, chemokines, growth factors, and hormones were measured in trial participants and control plasma samples using a multiplex immunoassay. Analyte levels were analysed using principle component analysis, cluster analysis and limma. Blood neutrophil counts were analysed using linear regression. RESULTS: Plasma analyte levels of HIV-infected individuals are markedly different from those of healthy controls and HIV-negative individuals receiving post-exposure prophylaxis. Viral reactivation following cART interruption also affects multiple analytes, but cART interruption itself only has only a minor effect. We find that Thyroxine-Binding Globulin (TBG) levels and late-stage neutrophil numbers correlate with the time off cART after DC vaccination. Furthermore, analysis shows that cART alters several regulators of blood glucose levels, including C-peptide, chromogranin-A and leptin. HIV reactivation is associated with the upregulation of CXCR3 ligands. CONCLUSIONS: Chronic HIV infection leads to a change in multiple plasma analyte levels, as does virus reactivation after cART interruption. Furthermore, we find evidence for the involvement of TBG and neutrophils in the response to DC-vaccination in the setting of HIV-infection

Regge residues from DGLAP evolution

We show that combining forward and backward evolution allows to extract the residues of the triple-pole pomeron and of the other singularities for 10 GeV$^2 \le Q^2 \le 1000$ GeV$^2$. In this approach, the essential singularity generated by the DGLAP evolution is considered as a numerical approximation to a triple-pole pomeron. Using an analytical expression for the form factors, we reproduce the experimental data with a $\chi^2/dof$ of 1.02. This proves the compatibility between Regge theory and DGLAP evolution. The method used here enables us to evaluate the uncertainties on the gluon distribution which prove to be large at small $x$ and small $Q^2$.Comment: 11 pages, 9 figures, RevTeX 4, Submitted to Phys. Re

DGLAP evolution extends the triple pole pomeron fit

We show that the triple pole pomeron model \cite{CMS} provides an initial condition for a DGLAP evolution \cite{DGLAP} that produces a fit to high $Q^2$ experimental DIS data. We obtain good $\chi^2$ for initial scales down to 3 GeV$^2$. Values of the initial scale smaller than 1.45 GeV$^2$ are ruled out at the 90% confidence level.Comment: 8 pages, 6 figures, uses RevTex 4. Typos corrected, some points clarifed and 1 figure adde

Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitment

Objectives To characterize the host response to dendritic cell-based immunotherapy and subsequent combined antiretroviral therapy (cART) interruption in HIV-1-infected individuals at the plasma protein level. Design An autologous dendritic cell (DC) therapeutic vaccine was administered to HIV-infected individuals, stable on cART. The effect of vaccination was evaluated at the plasma protein level during the period preceding cART interruption, during analytical therapy interruption and at viral reactivation. Healthy controls and post-exposure prophylactically treated healthy individuals were included as controls. Methods Plasma marker (‘analyte’) levels including cytokines, chemokines, growth factors, and hormones were measured in trial participants and control plasma samples using a multiplex immunoassay. Analyte levels were analysed using principle component analysis, cluster analysis and limma. Blood neutrophil counts were analysed using linear regression. Results Plasma analyte levels of HIV-infected individuals are markedly different from those of healthy controls and HIV-negative individuals receiving post-exposure prophylaxis. Viral reactivation following cART interruption also affects multiple analytes, but cART interruption itself only has only a minor effect. We find that Thyroxine-Binding Globulin (TBG) levels and late-stage neutrophil numbers correlate with the time off cART after DC vaccination. Furthermore, analysis shows that cART alters several regulators of blood glucose levels, including C-peptide, chromogranin-A and leptin. HIV reactivation is associated with the upregulation of CXCR

A Step Beyond the Bounce: Bubble Dynamics in Quantum Phase Transitions

We study the dynamical evolution of a phase interface or bubble in the context of a \lambda \phi^4 + g \phi^6 scalar quantum field theory. We use a self-consistent mean-field approximation derived from a 2PI effective action to construct an initial value problem for the expectation value of the quantum field and two-point function. We solve the equations of motion numerically in (1+1)-dimensions and compare the results to the purely classical evolution. We find that the quantum fluctuations dress the classical profile, affecting both the early time expansion of the bubble and the behavior upon collision with a neighboring interface.Comment: 12 pages, multiple figure